Deals

PK Picks Up Puhdistamo To Grow In Nordic Consumer Health Market

 
• By 

PK Consumer Health - formerly known as PK Benelux - has added to its VMS offering with a deal for Finland's Puhdistamo.

Olyos Looks To LATAM To Accelerate Growth

 
• By 

Dietary supplements firm Olyos puts to use recently raised funds with the acquisition of Chile's Newscience.

Valbiotis Spies Opportunity In Middle East

 
• By 

French firm will take its plant-based supplements to the Middle East through a deal with local player Mena Nutrition.

Vision Healthcare Picks Up Alpha Foods From Karo

 
• By 

Vision Healthcare said it had strengthened its position in the DACH markets after securing the acquisition of supplements firm Alpha Foods from Karo Healthcare.


Germany’s Carbyne Moves Into Nutraceuticals With SuanNutra

 
• By 

Private-equity firm Carbyne has snapped up European and US nutraceutical ingredients supplier SuanNutra from its Spanish parent company.

Vision Healthcare Grows VMS Offering With Sweden’s BioSalma

 
• By 

Vision Healthcare adds an established supplements portfolio, alongside a robust omni-channel set-up across the Nordics, with the acquisition of BioSalma.

C&D Pulls Curtain Down On Gummy Vitamin Gambit With Sale To Piping Rock Health

 

Decision on vitafusion and L’il Critters business planned by end of year, but Piping Rock Health provided incentive for C&D to opt for divestiture.

Vision Healthcare Adds VitaYummy Gummies To Grow In Nordics

 
• By 

Belgian consumer health player Vision Healthcare has added to its supplements offering with a deal for Nordic Nutriment and its VitaYummy brand.


France’s ANJAC Snaps Up Health Chain Group To Grow In Nutraceuticals Market

 
• By 

HCG comprises PharmaLinea, Hermes Consilium and ErgoPharma and generates annual sales of around €30m.

Damier’s TOCG Grows With Denmark’s Hairlust

 
• By 

The Organic Consumer Group has bolstered its offering in Europe's beauty market with the acquisition of Denmark's Hairlust, known for its innovative haircare products.

SFI Spies Equazen Growth Potential In Belgium And Netherlands

 
• By 

Brain health supplement Equazen will be distributed by Curasense in its home market of Belgium and the Netherlands. Brain health is one of the most dynamic supplement categories in Europe, according to SFI.


Altea Sets Out Big Ambitions For Preventive Health Investments As It Seals First Deal

 
• By 

Investment fund Altea Capital Partners has an ambition to become “a center of gravity in the preventive health space in Europe.” Striking out towards that goal it has sealed the acquisition of dietary supplements player Holistic Sweden.

Novo Nordisk And Novonesis Team Up For Dietary Supplements Development

 
• By 

The Danish firms plan to develop and test synbiotic dietary supplements – combining probiotics and prebiotics – that can have a positive effect on an individual's metabolic health.

Omega Pharma Moves Into Beauty Nutraceuticals With Cieffe Derma Deal

 
• By 

21 Invest-backed Omega Pharma bolsters portfolio through acquisition of Cieffe Derma and its skin-care focused dietary supplements and topical products.

Avista Adds To EU Consumer Health Portfolio With PK Benelux Deal

 
• By 

Private equity firm Avista attracted by PK Benelux' "leadership in innovation" in the Dutch vitamins, minerals and supplements market.


OptiBiotix Enters US Supplements Market With Hydroxycut

 
• By 

UK's OptiBiotix believes its SlimBiome probiotic can cut through in the crowded US market for weight loss supplements.

Stada Acquires Fortacell To Grow In Balkans

 
• By 

Stada's Serbian subsidiary Hemofarm has enhanced its offering in the dietary supplements category with the acquisition of Fortacell from Goodwill Pharma.

Vision Healthcare Strikes Deals To Expand European Offering

 
• By 

Belgium-based Vision Healthcare has acquired Svenskt Kosttillskott in Sweden and New Care Supplements in the Netherlands.

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

 

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.